Qusai Y. Al–Share

2.6k total citations · 2 hit papers
23 papers, 2.0k citations indexed

About

Qusai Y. Al–Share is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Qusai Y. Al–Share has authored 23 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Cellular and Molecular Neuroscience and 5 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Qusai Y. Al–Share's work include Receptor Mechanisms and Signaling (6 papers), Neuropeptides and Animal Physiology (6 papers) and Cardiovascular and exercise physiology (5 papers). Qusai Y. Al–Share is often cited by papers focused on Receptor Mechanisms and Signaling (6 papers), Neuropeptides and Animal Physiology (6 papers) and Cardiovascular and exercise physiology (5 papers). Qusai Y. Al–Share collaborates with scholars based in United States, Jordan and Norway. Qusai Y. Al–Share's co-authors include Sonia M. Najjar, Per Magnus Haram, Ulrik Wisløff, Sang Jun Lee, Ole Johan Kemi, Øivind Rognmo, Tomas Stølen, Anja Bye, Eirik Skogvoll and Arnt Erik Tjønna and has published in prestigious journals such as Science, Journal of Biological Chemistry and Circulation.

In The Last Decade

Qusai Y. Al–Share

22 papers receiving 1.9k citations

Hit Papers

Aerobic Interval Training Versus Continuous Moderate Exer... 2005 2026 2012 2019 2008 2005 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qusai Y. Al–Share United States 17 923 789 674 426 288 23 2.0k
Isabelle de Glisezinski France 24 1.3k 1.5× 274 0.3× 583 0.9× 258 0.6× 331 1.1× 52 2.0k
Steven J. Prior United States 23 632 0.7× 240 0.3× 331 0.5× 363 0.9× 221 0.8× 72 1.5k
R. M. McAllister United States 26 694 0.8× 754 1.0× 886 1.3× 227 0.5× 57 0.2× 61 1.7k
Maria Fernström Sweden 17 936 1.0× 420 0.5× 197 0.3× 698 1.6× 166 0.6× 29 1.7k
Michael A. Horning United States 25 1.2k 1.3× 750 1.0× 187 0.3× 505 1.2× 122 0.4× 39 2.4k
Christopher M. Hearon United States 19 398 0.4× 384 0.5× 733 1.1× 199 0.5× 137 0.5× 78 1.4k
Guillaume Py France 21 685 0.7× 333 0.4× 112 0.2× 519 1.2× 137 0.5× 44 1.6k
S M Villares Brazil 25 433 0.5× 311 0.4× 448 0.7× 236 0.6× 82 0.3× 48 1.6k
Wulf Hildebrandt Germany 25 931 1.0× 210 0.3× 221 0.3× 664 1.6× 121 0.4× 82 2.3k
Michael Sagiv Israel 21 296 0.3× 289 0.4× 657 1.0× 137 0.3× 138 0.5× 65 1.5k

Countries citing papers authored by Qusai Y. Al–Share

Since Specialization
Citations

This map shows the geographic impact of Qusai Y. Al–Share's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qusai Y. Al–Share with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qusai Y. Al–Share more than expected).

Fields of papers citing papers by Qusai Y. Al–Share

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qusai Y. Al–Share. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qusai Y. Al–Share. The network helps show where Qusai Y. Al–Share may publish in the future.

Co-authorship network of co-authors of Qusai Y. Al–Share

This figure shows the co-authorship network connecting the top 25 collaborators of Qusai Y. Al–Share. A scholar is included among the top collaborators of Qusai Y. Al–Share based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qusai Y. Al–Share. Qusai Y. Al–Share is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Al–Share, Qusai Y., et al.. (2024). Evaluation of medication appropriateness index in cardiovascular outpatient clinic: A cross-sectional study. Currents in Pharmacy Teaching and Learning. 17(2). 102262–102262.
3.
Shatnawi, Aymen, et al.. (2022). Pharmacogenomics of Lipid-Lowering Agents: the Impact on Efficacy and Safety. Personalized Medicine. 20(1). 65–86. 1 indexed citations
4.
Heinrich, Garrett, Harrison T. Muturi, Khadijeh Rezaei, et al.. (2017). Reduced Hepatic Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1 Level in Obesity. Frontiers in Endocrinology. 8. 54–54. 16 indexed citations
5.
Heinrich, Garrett, Hilda E. Ghadieh, Simona S. Ghanem, et al.. (2017). Loss of Hepatic CEACAM1: A Unifying Mechanism Linking Insulin Resistance to Obesity and Non-Alcoholic Fatty Liver Disease. Frontiers in Endocrinology. 8. 8–8. 31 indexed citations
6.
Ramakrishnan, Sadeesh K., Saja S. Khuder, Qusai Y. Al–Share, et al.. (2016). PPARα (Peroxisome Proliferator-activated Receptor α) Activation Reduces Hepatic CEACAM1 Protein Expression to Regulate Fatty Acid Oxidation during Fasting-refeeding Transition. Journal of Biological Chemistry. 291(15). 8121–8129. 34 indexed citations
7.
Russo, Lucia, Hilda E. Ghadieh, Simona S. Ghanem, et al.. (2016). Role for hepatic CEACAM1 in regulating fatty acid metabolism along the adipocyte-hepatocyte axis. Journal of Lipid Research. 57(12). 2163–2175. 16 indexed citations
8.
Flarakos, Jimmy, Qusai Y. Al–Share, Priya Chandra, et al.. (2016). Disposition and metabolism of [14C] Sacubitril/Valsartan (formerly LCZ696) an angiotensin receptor neprilysin inhibitor, in healthy subjects. Xenobiotica. 46(11). 986–1000. 27 indexed citations
9.
Russo, Lucia, Simona S. Ghanem, Saja S. Khuder, et al.. (2015). Hepatic CEACAM1 Over-Expression Protects Against Diet-Induced Fibrosis and Inflammation in White Adipose Tissue. Frontiers in Endocrinology. 6. 116–116. 17 indexed citations
10.
Li, Caixia, et al.. (2015). High-fat diet amplifies renal renin angiotensin system expression, blood pressure elevation, and renal dysfunction caused by Ceacam1 null deletion. American Journal of Physiology-Endocrinology and Metabolism. 309(9). E802–E810. 22 indexed citations
11.
Tjønna, Arnt Erik, Øivind Rognmo, Tomas Stølen, et al.. (2009). Response to Letter Regarding Article, “Aerobic Interval Training Versus Continuous Moderate Exercise as a Treatment for the Metabolic Syndrome: A Pilot Study”. Circulation. 119(8). 17 indexed citations
12.
Lee, Sang Jun, Garrett Heinrich, Larisa Fedorova, et al.. (2008). Development of Nonalcoholic Steatohepatitis in Insulin-Resistant Liver-Specific S503A Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1 Mutant Mice. Gastroenterology. 135(6). 2084–2095. 34 indexed citations
13.
Haram, Per Magnus, Ole Johan Kemi, Sang Jin Lee, et al.. (2008). Aerobic interval training vs. continuous moderate exercise in the metabolic syndrome of rats artificially selected for low aerobic capacity. Cardiovascular Research. 81(4). 723–732. 159 indexed citations
14.
Tjønna, Arnt Erik, Sang Jun Lee, Øivind Rognmo, et al.. (2008). Aerobic Interval Training Versus Continuous Moderate Exercise as a Treatment for the Metabolic Syndrome. Circulation. 118(4). 346–354. 882 indexed citations breakdown →
15.
Tjønna, Arnt Erik, Per Magnus Haram, Sang Jin Lee, et al.. (2007). Superior Cardiovascular Effect Of Interval Training Versus Moderate Exercise In Patients With Metabolic Syndrome. Medicine & Science in Sports & Exercise. 39(5). s173–s173. 1 indexed citations
16.
Al–Share, Qusai Y., et al.. (2007). Exercise training increases hepatic CEACAM1 expression. The FASEB Journal. 21(6). 1 indexed citations
17.
Najjar, Sonia M., Yan Yang, Mats A. Fernström, et al.. (2005). Insulin acutely decreases hepatic fatty acid synthase activity. Cell Metabolism. 2(1). 43–53. 84 indexed citations
18.
Abou-Rjaily, George A., Sang Jun Lee, Denisa May, et al.. (2004). CEACAM1 modulates epidermal growth factor receptor–mediated cell proliferation. Journal of Clinical Investigation. 114(7). 944–952. 21 indexed citations
19.
Abou-Rjaily, George A., Sang Jun Lee, Denisa May, et al.. (2004). CEACAM1 modulates epidermal growth factor receptor–mediated cell proliferation. Journal of Clinical Investigation. 114(7). 944–952. 55 indexed citations
20.
Dai, Tong, George A. Abou-Rjaily, Qusai Y. Al–Share, et al.. (2004). Interaction between Altered Insulin and Lipid Metabolism in CEACAM1-inactive Transgenic Mice. Journal of Biological Chemistry. 279(43). 45155–45161. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026